The CYP2J2 G-50T polymorphism and myocardial infarction in patients with cardiovascular risk profile

BACKGROUND: Cytochrome P450 (CYP) enzyme 2J2, an epoxygenase predominantly expressed in the heart, metabolises arachidonic acid to biologically active eicosanoids. One of the CYP2J2 products, 11, 12-epoxyeicosatrienoic acid, has several vasoprotective effects. The CYP2J2-G-50T-promotor polymorphism...

Descripción completa

Detalles Bibliográficos
Autores principales: Börgel, Jan, Bulut, Daniel, Hanefeld, Christoph, Neubauer, Horst, Mügge, Andreas, Epplen, Jörg T, Holland-Letz, Tim, Spiecker, Martin
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2626571/
https://www.ncbi.nlm.nih.gov/pubmed/19105833
http://dx.doi.org/10.1186/1471-2261-8-41

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2626571/
https://www.ncbi.nlm.nih.gov/pubmed/19105833
http://dx.doi.org/10.1186/1471-2261-8-41

Ejemplares similares